导痰汤合身痛逐瘀汤加减联合常规化疗方案治疗多发性骨髓瘤临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R733.3

基金项目:


Clinical Study on Modified Daotan Tang and Shentong Zhuyu Tang Combined with Routine Chemotherapy Regimen for Multiple Myeloma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察导痰汤合身痛逐瘀汤加减联合来那度胺/地塞米松(RD) 方案治疗多发性骨髓瘤(MM) 的临床疗效。方法:将60 例MM 痰瘀痹阻证患者随机分为观察组和对照组各30 例。2 组均以来那度胺胶囊、醋酸地塞米松片治疗,观察组同期采用导痰汤合身痛逐瘀汤加减内服,治疗2 个疗程。于首次化疗后60 d 评估疗效,治疗前后以疼痛视觉模拟法(VAS) 评价骨痛程度,评定Karnofsky 功能状态(KPS) 评分,应用美国国立癌症研究所的化疗药物不良反应(NCI-CTC AE) 记录系统评价不良反应发生情况。比较2 组的临床疗效。结果:治疗后,观察组临床疗效优于对照组(P<0.05)。2 组骨痛VAS 评分、KPS 评分均较治疗前下降(P<0.01)。观察组骨痛VAS 评分低于对照组(P<0.01),KPS 评分高于对照组(P<0.01)。观察组胃肠道反应、血液学毒性的发生率均低于对照组(P<0.05),周围神经病变、皮疹和背痛的发生率组间比较,差异均无统计学意义(P>0.05)。结论:导痰汤合身痛逐瘀汤加减联合RD 方案治疗MM 痰瘀痹阻证患者,可更为有效地减轻疼痛症状,提高患者的生活质量,减轻化疗的不良反应,提高临床治疗效果。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Daotan tang and Shentong zhuyu tang combined with lenalidomide/dexamethasone(RD) regimen for multiple myeloma(MM). Methods: A total of 60 cases of MM patients with phlegm-stasis-obstructing arthralgia syndrome were randomly divided into the observation group and the control group,30 cases in each group. Both groups were given lenalidomide capsules and dexamethasone tablets,and the observation group was additionally given oral administration of modified Daotan tang and Shentong zhuyu tang at the same period. Both groups were treated for two courses. The curative effect was evaluated on the 60th day after the first chemotherapy. Before and after treatment, the degree of bone pain was evaluated by Visual Analogue Scale(VAS); the score of Karnofsky Performancec Status(KPS) was evaluated; the incidence of adverse reactions was recorded and evaluated systematically via the National Cancer Institute Common Toxicity Criteria for Adverse Event(NCI- CTC AE). The clinical effect in the two groups was compared. Results:After treatment,the clinical effect in the observation group was better than that in the control group(P< 0.05). The scores of VAS of bone pain and KPS in the two groups were decreased when compared with those before treatment (P<0.01). The VAS score of bone pain in the observation group was lower than that in the control group(P<0.01),and the KPS score was higher(P<0.01). The incidences of gastrointestinal reactions and hematological toxicity in the observation group were lower than those in the control group(P<0.05);when compared the incidence of peripheral neuropathy,rash and back pain between the two groups,there was no significance in differences among the two groups(P>0.05). Conclusion:As for the treatment of MM patients with phlegm-stasis-obstructing arthralgia syndrome,the therapy of modified Daotan tang and Shentong zhuyu tang combined with RD regimen can more effectively relieve pain, reduce the adverse reactions of chemotherapy,and improve life quality and clinical effect.

    参考文献
    相似文献
    引证文献
引用本文

叶席忠.导痰汤合身痛逐瘀汤加减联合常规化疗方案治疗多发性骨髓瘤临床研究[J].新中医,2020,52(20):46-48

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-10-19
  • 出版日期: